Literature DB >> 16940966

Selection of differentially expressed genes in microarray data analysis.

J J Chen1, S-J Wang, C-A Tsai, C-J Lin.   

Abstract

One common objective in microarray experiments is to identify a subset of genes that express differentially among different experimental conditions, for example, between drug treatment and no drug treatment. Often, the goal is to determine the underlying relationship between poor versus good gene signatures for identifying biological functions or predicting specific therapeutic outcomes. Because of the complexity in studying hundreds or thousands of genes in an experiment, selection of a subset of genes to enhance relationships among the underlying biological structures or to improve prediction accuracy of clinical outcomes has been an important issue in microarray data analysis. Selection of differentially expressed genes is a two-step process. The first step is to select an appropriate test statistic and compute the P-value. The genes are ranked according to their P-values as evidence of differential expression. The second step is to assign a significance level, that is, to determine a cutoff threshold from the P-values in accordance with the study objective. In this paper, we consider four commonly used statistics, t-, S- (SAM), U-(Mann-Whitney) and M-statistics to compute the P-values for gene ranking. We consider the family-wise error and false discovery rate false-positive error-controlled procedures to select a limited number of genes, and a receiver-operating characteristic (ROC) approach to select a larger number of genes for assigning the significance level. The ROC approach is particularly useful in genomic/genetic profiling studies. The well-known colon cancer data containing 22 normal and 40 tumor tissues are used to illustrate different gene ranking and significance level assignment methods for applications to genomic/genetic profiling studies. The P-values computed from the t-, U- and M-statistics are very similar. We discuss the common practice that uses the P-value, false-positive error probability, as the primary criterion, and then uses the fold-change as a surrogate measure of biological significance for gene selection. The P-value and the fold-change can be pictorially shown simultaneously in a volcano plot. We also address several issues on gene selection.

Entities:  

Mesh:

Year:  2006        PMID: 16940966     DOI: 10.1038/sj.tpj.6500412

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  33 in total

1.  Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays.

Authors:  Shen Hu; Arjan Vissink; Martha Arellano; Caroline Roozendaal; Hui Zhou; Cees G M Kallenberg; David T Wong
Journal:  Proteomics       Date:  2011-03-17       Impact factor: 3.984

2.  IL-36γ (IL-1F9) is a biomarker for psoriasis skin lesions.

Authors:  Angelo Massimiliano D'Erme; Dagmar Wilsmann-Theis; Julia Wagenpfeil; Michael Hölzel; Sandra Ferring-Schmitt; Sonja Sternberg; Miriam Wittmann; Bettina Peters; Andreas Bosio; Thomas Bieber; Joerg Wenzel
Journal:  J Invest Dermatol       Date:  2014-12-19       Impact factor: 8.551

3.  Expression of the H+-ATPase AHA10 proton pump is associated with citric acid accumulation in lemon juice sac cells.

Authors:  Alessio Aprile; Claire Federici; Timothy J Close; Luigi De Bellis; Luigi Cattivelli; Mikeal L Roose
Journal:  Funct Integr Genomics       Date:  2011-05-10       Impact factor: 3.410

4.  Expression of migration-related genes is progressively upregulated in murine Lineage-Sca-1+c-Kit+ population from the fetal to adult stages of development.

Authors:  Jesús Ciriza; Marcos E García-Ojeda
Journal:  Stem Cell Res Ther       Date:  2010-05-20       Impact factor: 6.832

5.  Functional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes.

Authors:  W Shi; M Bessarabova; D Dosymbekov; Z Dezso; T Nikolskaya; M Dudoladova; T Serebryiskaya; A Bugrim; A Guryanov; R J Brennan; R Shah; J Dopazo; M Chen; Y Deng; T Shi; G Jurman; C Furlanello; R S Thomas; J C Corton; W Tong; L Shi; Y Nikolsky
Journal:  Pharmacogenomics J       Date:  2010-08       Impact factor: 3.550

6.  Prediction of the outcome of preoperative chemotherapy in breast cancer using DNA probes that provide information on both complete and incomplete responses.

Authors:  René Natowicz; Roberto Incitti; Euler Guimarães Horta; Benoît Charles; Philippe Guinot; Kai Yan; Charles Coutant; Fabrice Andre; Lajos Pusztai; Roman Rouzier
Journal:  BMC Bioinformatics       Date:  2008-03-15       Impact factor: 3.169

7.  Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity.

Authors:  Viviane Zorzanelli Rocha; Eduardo J Folco; Galina Sukhova; Koichi Shimizu; Israel Gotsman; Ashley H Vernon; Peter Libby
Journal:  Circ Res       Date:  2008-07-24       Impact factor: 17.367

8.  Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.

Authors:  Arman Jahangiri; Michael De Lay; Liane M Miller; W Shawn Carbonell; Yu-Long Hu; Kan Lu; Maxwell W Tom; Jesse Paquette; Taku A Tokuyasu; Sean Tsao; Roxanne Marshall; Arie Perry; Kirsten M Bjorgan; Myriam M Chaumeil; Sabrina M Ronen; Gabriele Bergers; Manish K Aghi
Journal:  Clin Cancer Res       Date:  2013-01-10       Impact factor: 12.531

9.  CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Authors:  Gwladys Zabouo; Anne-Marie Imbert; Jocelyne Jacquemier; Pascal Finetti; Thomas Moreau; Benjamin Esterni; Daniel Birnbaum; François Bertucci; Christian Chabannon
Journal:  Breast Cancer Res       Date:  2009-01-05       Impact factor: 6.466

10.  Transcriptional profiling in response to terminal drought stress reveals differential responses along the wheat genome.

Authors:  Alessio Aprile; Anna M Mastrangelo; Anna M De Leonardis; Gabor Galiba; Enrica Roncaglia; Francesco Ferrari; Luigi De Bellis; Luana Turchi; Giovanni Giuliano; Luigi Cattivelli
Journal:  BMC Genomics       Date:  2009-06-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.